I am excited to bring you our endolift double chin solution, designed for serious clinics and cosmetic brands seeking ODM partnerships. I can offer flexible ODM routes and a high-quality endolift double chin Product that can be private-labeled to fit your market. We combine proven technique with a compact, easy-to-integrate system that reduces downtime for patients and speeds up your through-put in clinics. Our design features include a safe, minimally invasive approach, reliable power source, and consumables that meet international standards. For ODM customers, we provide full design files, regulatory documentation, training, and after-sales support to ensure you can scale. The Product is ready for your packaging, labeling, and marketing claims, with competitive MOQs and fast lead times. With us, you have a partner who understands the demand in med-aesthetics and supports growth through tailored solutions, dependable supply, and clear documentation. Endolift double chin—your next best selling treatment.
For clinics and distributors pursuing a best-in-class non-surgical option for submental fullness, energy-based lifting offers a compelling approach. By delivering controlled energy to the deep subcutaneous plane, tissue remodeling occurs with tightening that yields a natural jawline and shorter downtime. The result is a predictable, patient-friendly treatment that can expand non-surgical offerings, increase throughput, and improve patient satisfaction across diverse markets. This approach often outperforms competitive non-surgical options in downtime, consistency, and natural results. From a global procurement perspective, buyers should assess regulatory status, quality management (ISO 13485), and traceability of components. Evaluate device reliability, availability of consumables, and the depth of the supplier’s training and after-sales support. Consider total cost of ownership, including disposables, warranty, maintenance, and potential service intervals. Also review lead times, logistics, regional approvals, and the supplier’s clinical evidence and post-market support to ensure steady supply, strong performance, and consistent clinical outcomes.